Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.95 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.95 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.95 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.95 |
| ▸ | CES2 | O00748 | 1/20 | 0.67 |
| ▸ | CES1 | P23141 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | GSK3B | P49841 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.53 |
| ▸ | NPC1 | O15118 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | PKM | P14618 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Picolinic Acid SCHEMBL1462616 | 1.00 | LMNA (0.95) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL664133 | 1.00 | LMNA (0.95) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL674979 | 1.00 | LMNA (0.95) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL29480469 | 1.00 | LMNA (0.95) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL29360523 | 1.00 | LMNA (0.95) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL27680667 | 0.98 | LMNA (0.91) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL28174521 | 0.98 | LMNA (0.91) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL6285136 | 0.98 | LMNA (0.91) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL27695178 | 0.98 | LMNA (0.91) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL674837 | 0.98 | LMNA (1.00) | LMNAL3MBTL1NAPRTP4HTMCES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7733 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026102153-A1 | POSTBIOTIC AND HERBAL BLEND FOR REGULATING METABOLIC PROCESSES AND PROMOTING WEIGHT LOSS | Resbiotic Nutrition, Inc. (US) | 2026-05-15 | — | — | WO | claimed |
| CN-122004422-A | Delicious sea cucumber with auxiliary effect of improving sugar metabolism and preparation method thereof | 大连工业大学 | 2026-05-12 | — | — | CN | claimed |
| CN-122011158-A | Bovine serum albumin-derived multifunctional peptide with functions of antioxidation, blood glucose reduction and tyrosinase inhibition, and preparation and application thereof | 宁波大学 | 2026-05-12 | — | — | CN | claimed |
| US-12616232-B2 | Fasting mimicking diet | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2026-05-05 | — | — | US | claimed |
| US-20260101917-A1 | Hydrolyzed Pea Protein-Based Nutrient Composition | KATE FARMS INC (US) | 2026-04-16 | — | — | US | claimed |
| EP-4724049-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | Catalent Ontario Limited (CA) | 2026-04-15 | — | — | EP | claimed |
| US-20260077020-A1 | ORAL PEPTIDE PHARMACEUTICAL COMPOSITION THAT FACILITATES ENHANCED ORAL ABSORPTION | LE ROUX DANIELLE MARIE (US) | 2026-03-19 | — | — | US | claimed |
| US-12558370-B2 | Intact pea protein-based nutrient composition | KATE FARMS, INC. (US) | 2026-02-24 | — | — | US | claimed |
| EP-4687486-A1 | NOVEL COMBINATIONS COMPRISING KONJAC MANNAN, THEIR COMPOSITIONS AND USES THEREOF | Vivatis Pharma GmbH (DE) | 2026-02-11 | — | — | EP | claimed |
| EP-4687485-A1 | NOVEL COMBINATIONS COMPRISING KONJAC MANNAN, THEIR COMPOSITIONS AND USES THEREOF | Vivatis Pharma GmbH (DE) | 2026-02-11 | — | — | EP | claimed |
| WO-1995011034-A1 | COMPOSITION FOR WEIGHT REDUCTION CONTAINING EPHEDRINE AND A MINERAL SALT OR CHELATE | KEOWN WENDY J (US) | 1995-04-27 | — | — | WO | claimed |
| EP-0611570-A1 | Use of chromic tripicolinate in the treatment of obese diabetic patients | SANDOZ NUTRITION LTD. (CH) | 1994-08-24 | — | — | EP | claimed |
| US-5336672-A | Increasing egg production in poultry | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 1994-08-09 | — | — | US | claimed |
| US-5175156-A | Controlling blood serum lipid levels | NUTRITION 21 (US) | 1992-12-29 | — | — | US | claimed |
| US-5164384-A | Anabolic mineral formula | METAGENICS, INC. (US) | 1992-11-17 | — | — | US | claimed |
| US-RE33988-E | Dietary supplementation with essential metal picolinates | The United States of America as repesented by the Secretary of Agriculture (US) | 1992-07-07 | — | — | US | claimed |
| US-5087624-A | Administering to increase lean body mass in mammals | NUTRITION 21 (US) | 1992-02-11 | — | — | US | claimed |
| US-5087623-A | Reducing hyperglycemia and stabilizing the level of serum glucose in humans | NITRITION 21 (US) | 1992-02-11 | — | — | US | claimed |
| US-5013752-A | Food Bar Containing Chromium Picolinate | DOBBINS JOHN P (US) | 1991-05-07 | — | — | US | claimed |
| US-4918102-A | Prevention and treatment of alcoholism by the use of dietary chromium | DOBBINS JOHN P (US) | 1990-04-17 | — | — | US | claimed |